Core Inflation Hits 32 as FirstQuarter Growth Slows Amid IranDriven Oil Surge April Jobs Report Preview What Economists Expect for the Cooling Labor Market Spruce Biosciences SPRB Delivers Q1 2026 Beat EPS 894 vs 899 Expected Hudson HPP Down 391 How Low Could It Go 20260515 Jobless Claims Hit Lowest Level Since MidMay Disneys Ahsoka Season 2 Shows Cost Discipline 30 Cheaper Than The Acolyte Analyst Report on Walmart Inc Key Insights and Market Implications DeepSeek AI Claims CostEffective HighPerformance Models Without Premium Chips Scams Surge in Sophistication Global Fightback Gains Momentum Caribbean Beach Access Under Threat Foreign Developers and Local Backlash in Barbuda Grenada and Jamaica RCUS Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick UROY Q1 2026 Earnings Strong EPS Beat as Uranium Royalty Income Surprises CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline MAA Q1 2026 Earnings Strong EPS Surprise of 31 Amid Mixed Revenue Visibility Fresh Del Monte Produce Inc FDP Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Gain Sweetgreen Inc SG Slides 532 Key Support Levels in Focus After Sharp Pullback Tri Pointe Homes Inc TPH Holds Steady Near 47 as Housing Sector Consolidates Galaxy Digital GLXY Slips 31 as Crypto Sentiment Softens Key Support Zone in Focus Exicure Inc XCUR Slips 36 as Shares Test Support Near 253 UBS Highlights TotalEnergies TTE as a Preferred European Energy Stock Goodyear GT Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Progress PINS Q1 2026 Earnings Profit Beat Drives Positive Momentum AEMD Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares CNA Financial Q1 2026 Earnings EPS Misses Estimates by 34 Stock Declines NECB Q1 2026 Earnings EPS Slightly Misses Estimates Amid Positive Market Sentiment ORKA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline ASST Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines ATNM Q1 2026 Earnings NarrowerthanExpected Loss Reflects Cost Discipline Amid IomabB Development